Rapidly and successful improvement of nail psoriasis with risankizumab

Diego Orsini; Alessia Pacifico; Paolo Iacovelli; Pasquale Frascione; Paola De Simone; Chiara Assorgi; Flavia Pigliacelli

doi:10.1002/ccr3.8035

Clinical Case Reports (Oct 2023)

Rapidly and successful improvement of nail psoriasis with risankizumab

Diego Orsini,
Alessia Pacifico,
Paolo Iacovelli,
Pasquale Frascione,
Paola De Simone,
Chiara Assorgi,
Flavia Pigliacelli

Affiliations

Diego Orsini: Clinical Dermatology Unit IFO‐San Gallicano Dermatological Institute‐IRCCS Rome Italy
Alessia Pacifico: Clinical Dermatology Unit IFO‐San Gallicano Dermatological Institute‐IRCCS Rome Italy
Paolo Iacovelli: Clinical Dermatology Unit IFO‐San Gallicano Dermatological Institute‐IRCCS Rome Italy
Pasquale Frascione: Oncologic and Preventive Dermatology Unit IFO‐San Gallicano Dermatological Institute‐IRCCS Rome Italy
Paola De Simone: Oncologic and Preventive Dermatology Unit IFO‐San Gallicano Dermatological Institute‐IRCCS Rome Italy
Chiara Assorgi: Section of Dermatology, Department of Clinical Medicine and Surgery University of Naples Federico II Napoli Italy
Flavia Pigliacelli: Clinical Dermatology Unit IFO‐San Gallicano Dermatological Institute‐IRCCS Rome Italy

DOI: https://doi.org/10.1002/ccr3.8035
Journal volume & issue: Vol. 11, no. 10
pp. n/a – n/a

Abstract

Read online

Key Clinical Message This clinical case demonstrates quick resolution of nail psoriasis in a patient treated with risankizumab, highlighting the role of IL‐23 in the pathogenesis of nail psoriasis.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords